 |
|
|
|
|
|
 |
Regulation & Policy |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
China’s Guidebook for Pharmaceutical Patent Protection
|
June 2008 |
£975 |
Latest Chinese Regulations for Imported Drug Registration
China Pharmaceutical Guidebook
|
June 2008 |
£905 |
Major World Markets for Stents and The Economics of Drug-Eluting Technology
|
May 2008 |
£1825 |
Monitoring and Ensuring Pharmaceutical Compliance
|
March 2008 |
£5015 |
Licensing Strategies - Examining Todays Pharmaceutical Licensing Trends
|
November 2007 |
£7600 |
Pharmaceutical Pricing And Reimbursement
Strategies For Market Access Across The Us, Europe, Japan And Other Key Geographies
|
November 2007 |
£1495 |
Pricing And Reimbursement Series
NICE Its Impact On The UK Healthcare System And Beyond
|
September 2007 |
£2005 |
A Guide to Drug Pricing and Reimbursement
|
September 2007 |
£1560 |
Validation of Pharmaceutical Processes, 3rd edition
|
September 2007 |
£170 |
Validation and Qualification in Analytical Laboratories, 2nd edition
|
August 2007 |
£130 |
Legislation and Industry Status of Human Organ Transplantation in China
|
May 2007 |
£48 |
Pharmacoeconomics and Health Outcomes
Driving Formulary Access and Reimbursement
|
May 2007 |
£5015 |
China Pharmaceutical Guidebook Series - Vol 1
A Comprehensive Guidebook for Foreign Pharmaceutical Companies
|
February 2007 |
£490 |
Good Laboratory Practice Regulations
4th edition
|
February 2007 |
£95 |
Rules and Guidance for Pharmaceutical Manufacturers and Distributors
|
February 2007 |
£40 |
China Pharmaceutical Guidebook Series - Vol 4
A Guidebook of Registration Application for Imported Traditional Chinese Medicines and Natural Medicines
|
February 2007 |
£490 |
How to React to Parallel Trade
|
January 2007 |
£1095 |
Eu Paediatric Medicines Regulation
Boon or Burden?
|
January 2007 |
£1095 |
Martindale 35th edition
The Complete Drug Reference
|
November 2006 |
£350 |
Prescribing Data Restriction Program (PDRP), The
Critical Assessment and Best Practices
|
September 2006 |
£980 |
Pharmacovigilance
Risk Management in Practice
|
July 2006 |
£1499 |
Drug Pedigree: FDA Says 2007
|
June 2006 |
£280 |
Pricing and Reimbursement in the US
Innovation and robust pharmacoeconomic analysis are ke
|
June 2006 |
£6495 |
Parallel Trade in Europe and the US
The challenges facing pharma
|
April 2006 |
£3690 |
Pharmaceutical Pricing, Reimbursement and Parallel Trade 2006
|
March 2006 |
£1305 |
Drug Safety Versus Consumer Privacy
Must We Choose?
|
February 2006 |
£835 |
Managed Markets
Pharmaceutical Reimbursement Strategy, Organizational Structure and Medicare Part D
|
February 2006 |
£2865 |
Pharmaceutical Regulatory Affairs in The Eu & US
|
January 2006 |
£1095 |
Patent Law and Practice in Pharmaceuticals
|
January 2006 |
£1095 |
Pricing & Reimbursement in Asia-Pacific
|
January 2006 |
£1095 |
Pharmaceutical Regulatory Industry
|
January 2006 |
£3160 |
Integrated Intellectual Asset Management
A Guide to Exploiting and Protecting your Organization's Intellectual Assets
|
December 2005 |
£55 |
Pharmaceutical Pricing in the US and Europe
Analysis of Resources, Strategy and Structure
|
November 2005 |
£2865 |
Guide to Pharma Pricing & Reimbursement Systems
Western Europe
|
November 2005 |
£970 |
Stockley's Drug Interactions
7th Edition
|
October 2005 |
£120 |
Food-Drug Synergy and Safety
|
August 2005 |
£74.99 |
EU Pharma IMPACTS
|
August 2005 |
£450 |
Dictionary of Pharmacovigilance
1st Edition
|
June 2005 |
£65 |
Pricing & Reimbursement of Medicines in the United Kingdom
Understanding the pharmaceutical market in the healthcare system
|
June 2005 |
£450 |
US Drug Reimportation
Prospects & Opportunities
|
May 2005 |
£495 |
Adverse Event Reporting and Pharmacovigilance
Making Drug Safety Happen
|
April 2005 |
£2500 |
Validating Pharmaceutical Systems
Good Computer Practice in Life Science Manufacturing
|
March 2005 |
£140 |
Regulations in Global Pharma Industry
|
March 2005 |
£50 |
Write it Down
Guidance for Preparing Effective and Compliant Documentation, Second Edition
|
March 2005 |
£130 |
Introduction to Pharmaceutical Calculations
2nd Edition
|
March 2005 |
£19.95 |
FDA Administrative Enforcement Manual
|
February 2005 |
£100 |
Lincoln Technologies: Strategic Pharmacovigilance
|
January 2005 |
£445 |
Pharmacoeconomics & Success in the Marketplace
|
January 2005 |
£1499 |
Drug Safety in the Post-Vioxx Era
New legislation, regulation and company strategies in Europe and the US
|
January 2005 |
£1495 |
Worldwide Regulatory Compliance Issues in Life Science
|
January 2005 |
£2500 |
Pharmaceutical Pricing Strategies
Price optimization, reimbursement and regulation in Europe, US and Japan
|
January 2005 |
£1495 |
Pharmaceutical Anti-Counterfeiting Strategies
Protecting profits through operational security, new technologies and industry partnerships
|
January 2005 |
£1495 |
U.S. Regulatory Reporter Newsletter for Addresses in Europe
|
December 2004 |
£155 |
U.S. Regulatory Reporter Newsletter for Addresses in North America
|
December 2004 |
£145 |
Introduction to the Pharmaceutical Regulatory Process
|
November 2004 |
£94 |
Biologics Development
A Regulatory Overview 3rd Edition (2004)
|
October 2004 |
£55 |
Pharmaceutical Pricing: global perspectives
|
September 2004 |
£625 |
State-by-State Clinical Trial Requirements Reference Guide
|
September 2004 |
£10 |
PharmaHandbook: European Union (EU)
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
PharmaHandbook: Middle East & Africa
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
PharmaHandbook: Asia, Pacific
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
PharmaHandbook: North America
A Guide to the International Pharmaceutical Industry
|
June 2004 |
£125 |
European Pharmaceutical Regulation
Implications for Competitiveness, Innovation and a Single Market
|
March 2004 |
£150 |
Handbook of SOPs for Good Clinical Practice
Second Edition
|
February 2004 |
£140 |
Pharmaceutical Pricing & Reimbursement in European Union Accession Countries
A Concise Guide
|
January 2004 |
£995 |
Challenge of CMC Regulatory Compliance for Biopharmaceuticals, The
|
December 2003 |
£77.5 |
Electronic Record Keeping
Achieving and Maintaining Compliance with 21 CFR Part 11 and 45 CFR Parts 160, 162, and 164
|
December 2003 |
£140 |
FDA Regulatory Affairs
A Guide for Prescription Drugs, Medical Devices, and Biologics
|
December 2003 |
£95 |
Computer Systems Validation
Quality Assurance, Risk Management, and Regulatory Compliance for Pharmaceutical and Healthcare Companies
|
December 2003 |
£299 |
Compact Regs Parts 807, 812, and 814
CFR 21 Parts 807, 812, and 814 Medical Device Approval (10 Pack)
|
November 2003 |
£54.99 |
Compact Regs Parts 820
CFR 21 Part 820 Quality System Regulation (10 Pack)
|
November 2003 |
£55 |
Compact Regs Part 58
CFR 21 Part 58 Good Laboratory Practice for Non-clinical Laboratory Studies (10 Pack)
|
November 2003 |
£55 |
Compact Regs Parts 50, 54, 56, and 312
CFR 21 Parts 50, 56, and 312 Good Clinical Practices (10 Pack)
|
November 2003 |
£85 |
Compact Regs Part 11
|
October 2003 |
£55 |
The Control of Entry Regulations and Retail Pharmacy Services in the UK
Response to Health Select Committee 5th Report
|
July 2003 |
£4.5 |
Pharmaceutical Pricing Compendium
A practical guide to the pricing and reimbursement of medicines
|
March 2003 |
£125 |
Health Economics in the Drug Life Cycle
Achieving success in drug discovery, development, reimbursement and marketing
|
January 2003 |
£695 |
Pharmaceutical Pricing and Reimbursement
A concise guide
|
December 2002 |
£995 |
Worldwide Pharmaceutical Regulation Series
2002
|
December 2002 |
£185 |
Protecting Medicines and Pharmaceuticals
A Manual of AntiCounterfeiting Solutions
|
December 2002 |
£112 |
New Drug Approval in the European Union
|
November 2002 |
£70 |
Pharmaceutical Pricing & Reimbursement Systems of CEE
|
June 2002 |
£300 |
Pharmacoeconomics
A concise guide
|
January 2002 |
£995 |
Good Laboratory and Clinical Practice
Requirements for Compliance in the Global Pharmaceutical Industry
|
March 2001 |
£39.99 |
Medical Device Development
A Regulatory Overview 2000
|
December 2000 |
£55 |
Emerging Pharmaceutical Markets
Potential & Problems
|
September 2000 |
£195 |
Pharmaceutical Regulation in Europe
Industry Challenges
|
May 2000 |
£150 |
|
|
|
|
